TROG 91.01 - Head & Neck - Accelerated RT

TROG 19.06 DECREASE trial marks recruitment milestone

Read our latest Annual Report highlighting TROG achievements

By w.paterson
15 August, 2021
0 Comments

A Phase III Prospective Randomised Clinical Trial of Accelerated Radiotherapy (ART) for Stage III and IV Squamous Carcinoma of the Upper Aerodigestive Tract

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

24 July, 2025

Five questions about the inaugural World Radiotherapy Awareness Day: 7 September

LATEST NEWS: 24 July 2025 The inaugural World Radiotherapy

15 July, 2025

New paper outlines protocol for important TROG 20.01 CHEST-RT lung cancer trial

TRIAL UPDATE: 15 July 2025 The TROG 20.01 CHEST-RT

For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

Quick Links

Legalities

A Phase III Prospective Randomised Clinical Trial of Accelerated Radiotherapy (ART) for Stage III and IV Squamous Carcinoma of the Upper Aerodigestive Tract

TROG 92.01 – PCNSL (Phase II)

TROG 89.04 – Oesophageal – Synchronous RT & CT

Related Post

Five questions about the inaugural World Radiotherapy Awareness Day: 7 September

New paper outlines protocol for important TROG 20.01 CHEST-RT lung cancer trial

TROG 91.01 – Head & Neck – Accelerated RT

A Phase III Prospective Randomised Clinical Trial of Accelerated Radiotherapy (ART) for Stage III and IV Squamous Carcinoma of the Upper Aerodigestive Tract

TROG 92.01 – PCNSL (Phase II)

TROG 89.04 – Oesophageal – Synchronous RT & CT

Related Post

Five questions about the inaugural World Radiotherapy Awareness Day: 7 September

New paper outlines protocol for important TROG 20.01 CHEST-RT lung cancer trial